Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age related macular degeneration
|
663 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.900 | 0.980 | 51 | 2005 | 2019 | ||||
Myeloperoxidase Measurement
|
16 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.800 | 1.000 | 1 | 2013 | 2013 | ||||
Exudative age-related macular degeneration
|
109 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.740 | 1.000 | 5 | 2014 | 2017 | ||||
exudative macular degeneration
|
69 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
Matrix Metalloproteinase 8 Measurement
|
2 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.700 | 1.000 | 1 | 2017 | 2017 | ||||
von Willebrand's factor (lab test)
|
427 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.700 | 1.000 | 1 | 2013 | 2013 | ||||
Polypoidal choroidal vasculopathy
|
67 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.100 | 1.000 | 12 | 2008 | 2017 | ||||
Glycogen storage disease type II
|
269 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.100 | 1.000 | 10 | 2008 | 2018 | ||||
Central Serous Chorioretinopathy
|
10 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 0.500 | 2 | 2016 | 2018 | ||||
Lupus Erythematosus, Systemic
|
1172 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2011 | 2011 | ||||
Membranoproliferative Glomerulonephritis, Type II
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2008 | 2011 | ||||
Reticular pseudodrusen
|
10 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2014 | 2018 | ||||
Retinal angiomatous proliferation
|
4 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2010 | 2017 | ||||
Retinal pigment epithelium atrophy
|
2 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.020 | 1.000 | 2 | 2016 | 2017 | ||||
Acute anterior uveitis
|
30 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Acute central serous chorioretinopathy
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2019 | 2019 | ||||
Alzheimer's Disease
|
1843 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 | ||||
Anterior uveitis
|
20 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Atypical Hemolytic Uremic Syndrome
|
42 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2011 | 2011 | ||||
Choroidal vascular hyperpermeability
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetes
|
710 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetes Mellitus
|
824 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Diabetic Retinopathy
|
213 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||
Disseminated Intravascular Coagulation
|
3 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Geographic Atrophy
|
81 | 0.645 | 0.560 | 1 | 196673103 | missense variant | G/A | snv | 0.32 | 0.40 | 0.010 | 1.000 | 1 | 2016 | 2016 |